Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Marshall Urist

Evp, Research & Investments at Royalty Pharma plc (RPRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $12.5M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 5SEC RPRXRoyalty Pharma plc Sell Plan 4,126 $57.10 $236K -0.3%
Sep 30SEC RPRXRoyalty Pharma plc Sell Plan 4,1264,126 held (−50%) $57.88 $239K -1.6%
Jul 2SEC RPRXRoyalty Pharma plc Sell Plan 9,099 $55.88 $508K +1.9%
Jun 25SEC RPRXRoyalty Pharma plc Sell Plan 9,0989,099 held (−50%) $55.18 $502K +3.2%
May 21SEC RPRXRoyalty Pharma plc Sell Plan 13,68418,197 held (−43%) $52.75 $722K +7.9%
May 15SEC RPRXRoyalty Pharma plc Sell Plan 13,68431,881 held (−30%) $53.06 $726K +7.3%
Feb 2SEC RPRXRoyalty Pharma plc Sell Plan 20,000 $41.09 $822K +38.5%
Jan 26SEC RPRXRoyalty Pharma plc Sell Plan 20,00020,000 held (−50%) $40.26 $805K +41.4%
Jan 20SEC RPRXRoyalty Pharma plc Sell Plan 20,00040,000 held (−33%) $39.52 $790K +44.1%
Jan 13SEC RPRXRoyalty Pharma plc Sell Plan 20,00060,000 held (−25%) $40.78 $816K +39.6%
Jan 6SEC RPRXRoyalty Pharma plc Sell Plan 20,00080,000 held (−20%) $38.48 $770K +47.9%
Dec 29SEC RPRXRoyalty Pharma plc Sell Plan 20,000100,000 held (−17%) $39.32 $786K +44.8%
Dec 22SEC RPRXRoyalty Pharma plc Sell Plan 20,000120,000 held (−14%) $38.38 $768K +48.3%
Dec 17SEC RPRXRoyalty Pharma plc Sell Plan 20,000140,000 held (−12%) $38.32 $766K +48.6%
Dec 9SEC RPRXRoyalty Pharma plc Sell Plan 23,334160,000 held (−13%) $39.15 $914K +45.4%
Dec 9SEC RPRXRoyalty Pharma plc Sell Plan 18,2427,398 held (−71%) $39.15 $714K +45.4%
Dec 3SEC RPRXRoyalty Pharma plc Sell Plan 23,333183,334 held (−11%) $39.93 $932K +42.6%
Dec 3SEC RPRXRoyalty Pharma plc Sell Plan 18,24225,640 held (−42%) $39.90 $728K +42.7%
  • Sell

    Evp, Research & Investments Marshall Urist sold $236K of RPRX at $57.10 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Research & Investments Marshall Urist sold $239K of RPRX at $57.88 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Research & Investments Marshall Urist sold $508K of RPRX at $55.88 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Research & Investments Marshall Urist sold $502K of RPRX at $55.18 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Research & Investments Marshall Urist sold $722K of RPRX at $52.75 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Research & Investments Marshall Urist sold $726K of RPRX at $53.06 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.